Rather than seeking a single cure — a magic bullet — for Alzheimer’s disease, a shotgun blast of different drugs with ...

MRI findings uncover an unexpected mismatch between Alzheimer’s pathology and cognitive function in a unique case study.

Researchers have used a new brain-mapping technique to identify memory-related brain cells vulnerable to protein buildup, a key factor in the development of Alzheimer's disease, an incurable, ...

Researchers analyzed the brain of a woman with down syndrome and Alzheimer’s disease, and were shocked to discover that ...

A US woman with Down syndrome exhibited no symptoms of Alzheimer’s disease despite her brain showing advanced pathology.

The brain of an American woman with Down syndrome showed all the classic signs of Alzheimer’s disease, yet she remained ...

Lecanemab is an antibody infusion therapy, developed by pharmaceutical company Eisai, which has been shown to slow cognitive ...

After she passed away, her brain was examined at the University of Pittsburgh's 7T Bioengineering Research Program, where ...

Decades of tests had shown that she had both Down syndrome and an intermediate level of Alzheimer's. Physical examinations ...

Despite her brain’s pathology indicating Alzheimer’s, we think that her cognitive stability could have been attributed to her ...

A decade after scientists in The Picower Institute for Learning and Memory at MIT first began testing whether sensory stimulation of the brain's 40Hz "gamma" frequency rhythms could treat Alzheimer's ...